<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02230826</url>
  </required_header>
  <id_info>
    <org_study_id>1302-T-HIPLTO-RM</org_study_id>
    <nct_id>NCT02230826</nct_id>
  </id_info>
  <brief_title>Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty</brief_title>
  <official_title>Multicentric Observational PMCF Study to Evaluate Long-term Outcome, Performance and Safety of Implantable Devices in Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corin</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This long-term outcomes study is designed to collect safety and efficacy data on designated,&#xD;
      commercially available, hip arthroplasty products.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Outcome data collected from this study will be used for Post Market Surveillance (PMS) and&#xD;
      Clinical Evaluations on Legacy Tornier hip devices and will support peer-reviewed&#xD;
      publications on products performance and safety at long term follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">May 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of long-term outcome after hip arthroplasty with Legacy Tornier implants.</measure>
    <time_frame>At 10 years</time_frame>
    <description>Implants revision rate at 10-year FU hip arthroplasty</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of long-term outcome after hip arthroplasty with Legacy Tornier implants at 15 and 20-year FU.</measure>
    <time_frame>at 15- and 20-year</time_frame>
    <description>Implants revision rate at 15- and 20-year FU.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of clinical performance of Legacy Tornier hip implants</measure>
    <time_frame>starting intraoperatively up to 20-year FU</time_frame>
    <description>Change of PROM scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Safety of Legacy Tornier hip implants</measure>
    <time_frame>starting intraoperatively up to 20-year FU</time_frame>
    <description>Number, severity and causal relationship of procedure or implant-related Adverse Events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological evaluation of positioning and osteointegration of Legacy Tornier hip implants.</measure>
    <time_frame>starting intraoperatively up to 20-year FU</time_frame>
    <description>Number, thickness and location of radiolucent lines, osteolysis and heterotopic ossifications reported via radiological evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of patient quality of life</measure>
    <time_frame>starting intraoperatively up to 20-year FU</time_frame>
    <description>Improvement of quality of life via EQ-5D-5L scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of patient satisfaction following surgery</measure>
    <time_frame>3 months ; 2.5-year; 6, 11, 15, 20-year visits</time_frame>
    <description>Improvement of patient's satisfaction</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Hip Replacement</condition>
  <condition>Primary, Secondary or Post-traumatic Osteoarthrosis</condition>
  <condition>Femur Head Necrosis</condition>
  <condition>Congenital Dislocations</condition>
  <condition>Primary and Revision Surgery</condition>
  <arm_group>
    <arm_group_label>Patients with Hip arthroplasty</arm_group_label>
    <description>Patients with Hip implants.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of patients with a partial or total hip replacement (legacy Tornier implants)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Man or woman &gt;18 years&#xD;
&#xD;
          -  Subjects with indication of arthroplasty surgery with Legacy Tornier hip devices which&#xD;
             are under assessment as part of this PMCF study (Appendix D)&#xD;
&#xD;
          -  Subjects who agreed for study participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with existing tumour and/or particularly high surgical risk-&#xD;
&#xD;
          -  Subjects with anaesthetic risk class IV or higher&#xD;
&#xD;
          -  Subjects under guardianship and/or unable to follow procedures or matters related to&#xD;
             the study (examples: Illiterate, recent psychotic or mania disorders and / or&#xD;
             inability to comply with usual follow-up visits.)&#xD;
&#xD;
          -  Contraindications for arthroplasty with a hip Legacy Tornier device (see&#xD;
             contraindications listed in the Instructions for use of the device).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Goulven Rochcongar, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanessa Grimaud</last_name>
    <email>vanessa.grimaud@coringroup.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Bordeaux - Groupe Hospitalier Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry FABRE, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Thierry FABRE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Régis BERNARD DE DOMPSURE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Régis BERNARD DE DOMPSURE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-François GONZALEZ, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régionnal d'Orléans - Site La Source</name>
      <address>
        <city>Orléans</city>
        <zip>45000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mazen ALI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mazen ALI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Arago</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorick PASSERON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dorick PASSERON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Croix Saint-Simon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine MOUTON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Antoine MOUTON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc LHOTELLIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital privé Saint-Martin</name>
      <address>
        <city>Pessac</city>
        <zip>33600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien PALLARO, MD</last_name>
    </contact>
    <investigator>
      <last_name>Julien PALLARO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Médipôle Garonne</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Jean Bernard</name>
      <address>
        <city>Valenciennes</city>
        <zip>59300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles BERTON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Charles BERTON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre BLAIRON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>August 29, 2014</study_first_submitted>
  <study_first_submitted_qc>September 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2014</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthroplasty</keyword>
  <keyword>Hip Replacement</keyword>
  <keyword>Acetabular cup</keyword>
  <keyword>Femoral stem</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Femur Head Necrosis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

